Of the 94 tumor tissue samples studied, the relative immunoreactivity of SAV1 was reduced in 11 (11.7%) and increased in 59 (62.8%) cases, while 24 (25.5%) tumor specimens showed similar levels of SAV1 immunoreactivity to their corresponding non-cancerous tissues cells (Figure 4A). The gene discussed is SAV1; the disease is neoplasm.